Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 50

2.

Cinnamoyl-based Nrf2-activators targeting human skin cell photo-oxidative stress.

Wondrak GT, Cabello CM, Villeneuve NF, Zhang S, Ley S, Li Y, Sun Z, Zhang DD.

Free Radic Biol Med. 2008 Aug 15;45(4):385-95. doi: 10.1016/j.freeradbiomed.2008.04.023.

3.

The in vivo gene expression signature of oxidative stress.

Han ES, Muller FL, Pérez VI, Qi W, Liang H, Xi L, Fu C, Doyle E, Hickey M, Cornell J, Epstein CJ, Roberts LJ, Van Remmen H, Richardson A.

Physiol Genomics. 2008 Jun 12;34(1):112-26. doi: 10.1152/physiolgenomics.00239.2007.

4.

The reactive oxygen-driven tumor: relevance to melanoma.

Fried L, Arbiser JL.

Pigment Cell Melanoma Res. 2008 Apr;21(2):117-22. doi: 10.1111/j.1755-148X.2008.00451.x. Review.

PMID:
18384505
5.

Zinc protects endothelial cells from hydrogen peroxide via Nrf2-dependent stimulation of glutathione biosynthesis.

Cortese MM, Suschek CV, Wetzel W, Kröncke KD, Kolb-Bachofen V.

Free Radic Biol Med. 2008 Jun 15;44(12):2002-12. doi: 10.1016/j.freeradbiomed.2008.02.013.

PMID:
18355458
6.

Cinnamaldehyde inhibits the tumor necrosis factor-alpha-induced expression of cell adhesion molecules in endothelial cells by suppressing NF-kappaB activation: effects upon IkappaB and Nrf2.

Liao BC, Hsieh CW, Liu YC, Tzeng TT, Sun YW, Wung BS.

Toxicol Appl Pharmacol. 2008 Jun 1;229(2):161-71. doi: 10.1016/j.taap.2008.01.021.

PMID:
18304597
7.

Reactive oxygen species may have antitumor activity in metastatic melanoma.

Tuma RS.

J Natl Cancer Inst. 2008 Jan 2;100(1):11-2. No abstract available.

8.

Experimental therapeutics: targeting the redox Achilles heel of cancer.

Cabello CM, Bair WB 3rd, Wondrak GT.

Curr Opin Investig Drugs. 2007 Dec;8(12):1022-37. Review.

PMID:
18058573
9.

Overcoming apoptosis deficiency of melanoma-hope for new therapeutic approaches.

Eberle J, Kurbanov BM, Hossini AM, Trefzer U, Fecker LF.

Drug Resist Updat. 2007 Dec;10(6):218-34. Review.

PMID:
18054518
10.
11.

Induction of G2/M arrest and apoptosis by sesquiterpene lactones in human melanoma cell lines.

Rozenblat S, Grossman S, Bergman M, Gottlieb H, Cohen Y, Dovrat S.

Biochem Pharmacol. 2008 Jan 15;75(2):369-82.

PMID:
17919456
12.
13.

Egr-1 abrogates the E2F-1 block in terminal myeloid differentiation and suppresses leukemia.

Gibbs JD, Liebermann DA, Hoffman B.

Oncogene. 2008 Jan 3;27(1):98-106.

PMID:
17599039
14.

Suppression of age-related inflammatory NF-kappaB activation by cinnamaldehyde.

Kim DH, Kim CH, Kim MS, Kim JY, Jung KJ, Chung JH, An WG, Lee JW, Yu BP, Chung HY.

Biogerontology. 2007 Oct;8(5):545-54.

PMID:
17486422
15.

A comparison of chemical, antioxidant and antimicrobial studies of cinnamon leaf and bark volatile oils, oleoresins and their constituents.

Singh G, Maurya S, DeLampasona MP, Catalan CA.

Food Chem Toxicol. 2007 Sep;45(9):1650-61.

PMID:
17408833
16.

Overexpression of Akt converts radial growth melanoma to vertical growth melanoma.

Govindarajan B, Sligh JE, Vincent BJ, Li M, Canter JA, Nickoloff BJ, Rodenburg RJ, Smeitink JA, Oberley L, Zhang Y, Slingerland J, Arnold RS, Lambeth JD, Cohen C, Hilenski L, Griendling K, Martínez-Diez M, Cuezva JM, Arbiser JL.

J Clin Invest. 2007 Mar;117(3):719-29.

17.

New perspectives on melanoma pathogenesis and chemoprevention.

Meyskens FL Jr, Farmer PJ, Yang S, Anton-Culver H.

Recent Results Cancer Res. 2007;174:191-5. Review.

PMID:
17302196
18.

Reactive oxygen species: a breath of life or death?

Fruehauf JP, Meyskens FL Jr.

Clin Cancer Res. 2007 Feb 1;13(3):789-94. Review.

19.

Dimethylfumarate impairs melanoma growth and metastasis.

Loewe R, Valero T, Kremling S, Pratscher B, Kunstfeld R, Pehamberger H, Petzelbauer P.

Cancer Res. 2006 Dec 15;66(24):11888-96.

20.

Motexafin gadolinium: a novel redox active drug for cancer therapy.

Magda D, Miller RA.

Semin Cancer Biol. 2006 Dec;16(6):466-76. Review.

PMID:
17112739
Items per page

Supplemental Content

Support Center